Florida Senate - 2022                        COMMITTEE AMENDMENT
       Bill No. CS for SB 768
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                   Comm: WD            .                                
                  03/01/2022           .                                

       The Committee on Appropriations (Rodriguez) recommended the
    1         Senate Amendment (with title amendment)
    3         Between lines 641 and 642
    4  insert:
    5         Section 8. Section 465.41, Florida Statutes, is created to
    6  read:
    7         465.41Distribution of compounded human drug products.—
    8         (1)It is the intent of the Legislature to enhance
    9  communication and maximize federal and state resources for
   10  oversight of compounded drugs produced by traditional pharmacies
   11  and to enact an information sharing agreement with the federal
   12  Food and Drug Administration as a tool to monitor such drug
   13  products.
   14         (2)On an annual basis, and within 90 days after the
   15  beginning of the calendar year, all licensees who ship
   16  compounded human drug products interstate shall report to the
   17  National Association of Boards of Pharmacy Information-Sharing
   18  Network the information required by the Memorandum of
   19  Understanding Addressing Certain Distributions of Compounded
   20  Human Drug Products between the department and the United States
   21  Food and Drug Administration as provided by the federal Food and
   22  Drug Administration. Licensees shall provide the information to
   23  the department promptly upon request. The board may adopt rules
   24  necessary to implement and administer this section.
   26  ================= T I T L E  A M E N D M E N T ================
   27  And the title is amended as follows:
   28         Between lines 41 and 42
   29  insert:
   30         creating s. 465.41, F.S.; providing legislative
   31         intent; providing reporting requirements for certain
   32         licensees who ship compounded human drug products
   33         interstate; authorizing the Board of Pharmacy to adopt
   34         rules;